very true, back in 20/21 in the era of low interest rates money was pouring into the vast majority of biotechs and reaching new highs daily. Fast forward to today and practically no new money is coming in and only when biotechs with solid announcements appear. History says when rates starts getting cut biotechs will start outperforming.
off course individual companies need to do their bit but any partnerships, T/Os etc in the sector will help the cause in the meantime
very true, back in 20/21 in the era of low interest rates money...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.77M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $461.4K | 1.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 134437 | 7 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |